Literature DB >> 14966559

HDL action on the vascular wall: is the answer NO?

Philip W Shaul1, Chieko Mineo.   

Abstract

Circulating levels of HDL cholesterol are inversely related to the risk of atherosclerosis, and therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study shows that HDL-associated lysophospholipids stimulate the production of the potent antiatherogenic signaling molecule NO by the vascular endothelium.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14966559      PMCID： PMC338271          DOI： 10.1172/JCI21072

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  31 in total

1.  High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.

Authors:  I S Yuhanna; Y Zhu; B E Cox; L D Hahner; S Osborne-Lawrence; P Lu; Y L Marcel; R G Anderson; M E Mendelsohn; H H Hobbs; P W Shaul
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

2.  Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

Authors:  B G Brown; X Q Zhao; A Chait; L D Fisher; M C Cheung; J S Morse; A A Dowdy; E K Marino; E L Bolson; P Alaupovic; J Frohlich; J J Albers
Journal:  N Engl J Med       Date:  2001-11-29       Impact factor: 91.245

Review 3.  The "best" of cholesterols, the "worst" of cholesterols: a tale of two receptors.

Authors:  M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

Review 4.  Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.

Authors:  M Krieger
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

5.  Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation.

Authors:  A Blair; P W Shaul; I S Yuhanna; P A Conrad; E J Smart
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

Review 6.  High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.

Authors:  W E Boden
Journal:  Am J Cardiol       Date:  2000-12-21       Impact factor: 2.778

7.  Protective effect of high density lipoprotein on endothelium-dependent vasodilatation.

Authors:  X P Li; S P Zhao; X Y Zhang; L Liu; M Gao; Q C Zhou
Journal:  Int J Cardiol       Date:  2000-05-31       Impact factor: 4.164

8.  Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.

Authors:  M E Brousseau; G P Eberhart; J Dupuis; B F Asztalos; A L Goldkamp; E J Schaefer; M W Freeman
Journal:  J Lipid Res       Date:  2000-07       Impact factor: 5.922

9.  HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from The Cleveland Clinic Foundation.

Authors:  J M Foody; F D Ferdinand; G L Pearce; B W Lytle; D M Cosgrove; D L Sprecher
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

10.  High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.

Authors:  A Uittenbogaard; P W Shaul; I S Yuhanna; A Blair; E J Smart
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157
View more
  13 in total

1.  High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.

Authors:  Waleed Ahmed; Gabriela Orasanu; Vedika Nehra; Liana Asatryan; Daniel J Rader; Ouliana Ziouzenkova; Jorge Plutzky
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

Review 2.  Apo a-I modulating therapies.

Authors:  Stephen J Nicholls
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

3.  Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis.

Authors:  Boris L Vaisman; Stephen J Demosky; John A Stonik; Mona Ghias; Cathy L Knapper; Maureen L Sampson; Cuilian Dai; Stewart J Levine; Alan T Remaley
Journal:  J Lipid Res       Date:  2011-10-27       Impact factor: 5.922

4.  Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.

Authors:  Christian Besler; Kathrin Heinrich; Lucia Rohrer; Carola Doerries; Meliana Riwanto; Diana M Shih; Angeliki Chroni; Keiko Yonekawa; Sokrates Stein; Nicola Schaefer; Maja Mueller; Alexander Akhmedov; Georgios Daniil; Costantina Manes; Christian Templin; Christophe Wyss; Willibald Maier; Felix C Tanner; Christian M Matter; Roberto Corti; Clement Furlong; Aldons J Lusis; Arnold von Eckardstein; Alan M Fogelman; Thomas F Lüscher; Ulf Landmesser
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

5.  High-density lipoprotein cholesterol efflux, nitration of apolipoprotein A-I, and endothelial function in obese women.

Authors:  Edward Vazquez; Amar A Sethi; Lita Freeman; Gloria Zalos; Hira Chaudhry; Erin Haser; Brittany O Aicher; Angel Aponte; Marjan Gucek; Gregory J Kato; Myron A Waclawiw; Alan T Remaley; Richard O Cannon
Journal:  Am J Cardiol       Date:  2011-11-19       Impact factor: 2.778

Review 6.  Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.

Authors:  Denise G Hemmings
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04       Impact factor: 3.000

7.  17β-Estradiol regulates scavenger receptor class BI gene expression via protein kinase C in vascular endothelial cells.

Authors:  Youko Fukata; Xiao Yu; Hitomi Imachi; Takamasa Nishiuchi; Jingya Lyu; Kayoko Seo; Akihiro Takeuchi; Hisakazu Iwama; Hisashi Masugata; Hiroshi Hoshikawa; Naohisa Hosomi; Yasumasa Iwasaki; Koji Murao
Journal:  Endocrine       Date:  2013-12-18       Impact factor: 3.633

8.  MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.

Authors:  Zhiliang Xu; Yeming Han; Jiying Liu; Fan Jiang; Huili Hu; Yan Wang; Qiji Liu; Yaoqin Gong; Xi Li
Journal:  Sci Rep       Date:  2015-07-17       Impact factor: 4.379

9.  A Novel Anti-Inflammatory Effect for High Density Lipoprotein.

Authors:  Scott J Cameron; Craig N Morrell; Clare Bao; AnneMarie F Swaim; Annabelle Rodriguez; Charles J Lowenstein
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

10.  Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond.

Authors:  Belinda A Di Bartolo; Daniel J Scherer; Stephen J Nicholls
Journal:  Arch Med Sci       Date:  2016-10-24       Impact factor: 3.318
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.